Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in chronic stable angina and CAD with type 2 diabetes
NCT01334203Phase 4Withdrawn
- Sponsor
- Gilead Sciences
- Start
- May 2011
- Primary completion
- Oct 2012
01
Overview
A Phase 4 trial of ranolazine in angina pectoris, sponsored by Gilead Sciences. Planned start May 2011; status: withdrawn.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01334203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334203.